The 2 Minute Medicine Podcast Episode 27
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
Tag: Coronavirus
Symptom and viral relapse more common in COVID-19 patients without antiviral treatment
1. In this retrospective analysis, symptom and viral rebound occurred in almost one-third of coronavirus disease 2019 (COVID-19) patients that ...
The 2 Minute Medicine Podcast Episode 6
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: the Future of Medicine, Neuralink, the Spotlight on Celine Dion and COVID-19 on Social Media
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Baricitinib reduces mortality risk in patients hospitalized with COVID-19
1. Baricitinib with usual care was associated with a 13% proportional reduction in mortality compared to treatment as usual care ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
Heparin in noncritically ill COVID-19 patients [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Interleukin-6 receptor antagonist treatment improves outcomes in patients with COVID-19 infection [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Nationwide vaccination campaign with BNT162b2 mRNA vaccine reports high immunogenicity across all age groups [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
The EMPACTA trial: Tocilizumab reduced COVID-19 disease-related adverse health outcomes [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...